A patient who received genetically modified CD4 T-cells lacking a co-receptor that enables HIV entry has maintained undetectable viral load during an antiretroviral treatment interruption lasting 14 weeks, according to a presentation at the annual meeting of the European Society of Gene and Cell Therapy taking place this week in Madrid.
http://www.hivandhepatitis.com/hiv-treatment/hiv-cure/4380-gene-therapy-study-participant-maintains-viral-suppression-off-art-sangamo-says
http://www.hivandhepatitis.com/hiv-treatment/hiv-cure/4380-gene-therapy-study-participant-maintains-viral-suppression-off-art-sangamo-says
No comments:
Post a Comment